Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-03

Clinical Trial Update: Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers [Phase 1]

View source ↗

Summary

This entry notes a Phase 1 clinical trial evaluating mavoglurant's effect on alcohol craving and drinking in heavy drinkers with alcohol use disorder, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mavoglurant (mavoglurant)

Snippet

Sponsor: Yale University | Conditions: Alcohol Consumption, Heavy Drinker | Phase 1 | Status: RECRUITING